Evidence map›Paper›PMID 37458047›Full record

ArticleJournal of Parkinson's disease2023

Screening Tools for Sarcopenia in Mild to Moderate Parkinson's Disease: Assessing the Accuracy of SARC-F and Calf Circumference.

João Rafael Gomes de Luna, Danielle Pessoa Lima, Vlademir Carneiro Gomes, Samuel Brito de Almeida, Pauliana Alencar Monteiro, Antonio Brazil Viana-Júnior, Thabta Aparecida Marques da Silva, Leticia Brasil Gradvohl, Luísa Bedê Bruno, Miriam Lindsay Silva Marques and 5 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

João Rafael Gomes de LunaDepartment of Clinical Medicine, Division of Geriatrics, Universidade Federal do Ceará, Fortaleza, Brazil.
Danielle Pessoa LimaDepartment of Clinical Medicine, Division of Geriatrics, Universidade Federal do Ceará, Fortaleza, Brazil.
Vlademir Carneiro GomesClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Samuel Brito de AlmeidaClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Pauliana Alencar MonteiroClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Antonio Brazil Viana-JúniorClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Thabta Aparecida Marques da SilvaClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Leticia Brasil GradvohlMedical School of Universidade de Fortaleza, Fortaleza, Brazil.
Luísa Bedê BrunoMedical School of Universidade de Fortaleza, Fortaleza, Brazil.
Miriam Lindsay Silva MarquesClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Letícia Chaves Vieira CunhaClinical Research Unit of Hospital Universitário Walter Cantídio, Universidade Federal do Ceará/Empresa Brasileira de Serviços Hospitalares (EBSERH), Fortaleza, Brazil.
Camila Ximenes FeitosaMedical School of Universidade de Fortaleza, Fortaleza, Brazil.
Pedro Braga-NetoDepartment of Clinical Medicine, Division of Neurology, Universidade Federal do Ceará, Fortaleza, Brazil.
Jarbas de Sá Roriz-FilhoDepartment of Clinical Medicine, Division of Geriatrics, Universidade Federal do Ceará, Fortaleza, Brazil.
Renan Magalhaes Montenegro-JúniorDepartment of Clinical Medicine, Division of Endocrinology and Metabolism, Universidade Federal do Ceará, Fortaleza, Brazil.
Universidade Federal do Ceará · BRUniversidade de Fortaleza · BRUniversidade Estadual do Ceará · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) and sarcopenia share similar pathophysiological mechanisms.

objectiveEstimate the prevalence of sarcopenia in PD patients and describe clinical and demographic features associated with sarcopenia.

methodsA cross-sectional study was carried out at a tertiary public hospital in Brazil. A modified HY scale of stage 1 to 3, being at least 40 years old and having the ability to stand and walk unassisted were required for eligibility. We evaluated physical performance and muscle mass using DEXA.

resultsThe study population comprised 124 patients, of which 53 (42.7%) were women. The mean age and mean disease duration were 65.8±10.5 and 10.1±5.8 years, respectively. The mean handgrip strength of 20.4±6.9 in woman and 34.6±8.4 kg in men. Moreover, 50.8% patients had positive SARC-F, 20% patients had probable sarcopenia, 9.6% confirmed sarcopenia, and 16.8% patients showed low muscle mass quantity measured by DEXA. Lower Levodopa Equivalent Dosage (LED) and calf circumference (CC) were independently associated with confirmed sarcopenia. LLED, higher MDS-UPDRS Part III, and lower MMSE scores were independently associated with probable sarcopenia. The CC demonstrated accuracy to identify PD patients with confirmed sarcopenia with a cut-off of <31 cm in women and <34 cm in men.

conclusionWe found low prevalence of confirmed sarcopenia among PD patients. We propose that healthcare providers introduce measuring CC, which is a quick and inexpensive method to assess for sarcopenia in PD patients.

Indexed as

Parkinson DiseaseSarcopeniaAdultCross-Sectional StudiesFemaleHand StrengthHumansLevodopaMaleSurveys and QuestionnairesLevodopaParkinson’s diseaseSarcopeniastrength

Identifiers

PMID37458047
PMCPMC10578260
OpenAlexW4384338215

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.